Agios Pharmaceuticals Inc (MEX:AGIO) Stock News, Headlines & Updates
Agios Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jul 22, 2025
Agios Pharmaceuticals (AGIO): Analyst Maintains Buy Rating, Lowers Price Target | AGIO Stock News
GuruFocus News • 11:37am
Agios Pharmaceuticals (AGIO): BofA Adjusts Price Target Amid Revenue Forecasts | AGIO Stock News
GuruFocus News • 5:47am
Jul 14, 2025
Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET | AGIO Stock News
GuruFocus News • 6:20am
Agios Pharmaceuticals Inc (AGIO) Announces Upcoming Q2 2025 Financial Results Conference Call | AGIO stock news
GuruFocus News • 6:03am
Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET
Marketwired • 6:00am
Jul 08, 2025
Agios Appoints Dr. Jay Backstrom to Board of Directors | AGIO Stock News
GuruFocus News • 6:21am
Agios Appoints Dr. Jay Backstrom to Board of Directors
Marketwired • 6:00am
Jun 26, 2025
AGIO STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) and Encourages Long-Term Investors to Contact the FirmÂ
Marketwired • 6:00am
Jun 09, 2025
Agios Pharmaceuticals (AGIO) Target Price Revised Amid New European Deal | AGIO Stock News
GuruFocus News • 11:45am
Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders | AGIO Stock News
GuruFocus News • 8:00am
May 28, 2025
Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025 | AGIO Stock News
GuruFocus News • 6:22am
Agios Pharmaceuticals Inc (AGIO) to Present at Goldman Sachs Annual Global Healthcare Conference | AGIO stock news
GuruFocus News • 6:06am
Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025
Marketwired • 6:00am
May 14, 2025
Agios Pharmaceuticals (AGIO) Highlights Promising Data at EHA 2025 | AGIO Stock News
GuruFocus News • 9:21am
Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress | AGIO Stock News
GuruFocus News • 9:16am
Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
Marketwired • 9:00am
May 09, 2025
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025 | AGIO Stock News
GuruFocus News • 6:21am
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025
Marketwired • 6:00am
May 03, 2025
Decoding Agios Pharmaceuticals Inc (AGIO): A Strategic SWOT Insight
GuruFocus News • 11:15pm
May 02, 2025
AGIO Receives Price Target Adjustment from Scotiabank | AGIO Stock News
GuruFocus News • 9:35am
Agios Pharmaceuticals (AGIO) Price Target Adjusted by Scotiabank Analyst | AGIO Stock News
GuruFocus News • 8:48am
Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025 | AGIO Stock News
GuruFocus News • 6:18am
Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025
Marketwired • 6:00am
Agios Pharmaceuticals Inc (AGIO) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid Revenue Challenges
GuruFocus News • 1:02am
Q1 2025 Agios Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News • 11:16pm
May 01, 2025
Agios (AGIO) Reports Lower Q1 Revenue as sNDA for Thalassemia Progresses | AGIO Stock News
GuruFocus News • 7:04am
Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights
Marketwired • 6:00am
Agios Pharmaceuticals Inc Reports Q1 2025 EPS of -$1.55, Beating Estimates; Revenue at $8.7 Million, Below Expectations
GuruFocus News • 5:51am
Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights | AGIO Stock News
GuruFocus News • 5:50am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news